ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

International Group Plans Survey On Thrombosis Risk

July 27, 2001

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery

April 20, 1990

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991